Advances in the diagnosis, pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus

被引:40
|
作者
Moore, Erica [1 ]
Huang, Michelle W. [1 ]
Putterman, Chaim [1 ,2 ,3 ]
机构
[1] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA
[2] Albert Einstein Coll Med, Div Rheumatol, F701N,1300 Morris Pk Ave, Bronx, NY 10461 USA
[3] Bar Ilan Univ, Azrieli Fac Med, Safed, Israel
基金
美国国家卫生研究院;
关键词
angiotensin-converting enzyme inhibitors; biomarkers; microglial activation; neuroimaging; neuropsychiatric lupus; systemic lupus erythematosus; BLOOD-BRAIN-BARRIER; AUTOANTIBODY; DAMAGES;
D O I
10.1097/BOR.0000000000000682
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review Diagnosing and treating neuropsychiatric systemic lupus erythematosus (NPSLE) remains challenging as the pathogenesis is still being debated. In this review, we discuss studies evaluating recent advances in diagnostic methods, pathogenic mediators and potential treatments. Recent findings Screening tools used for neurodegenerative diseases were found to be both sensitive and moderately specific for cognitive dysfunction in NPSLE. Neuroimaging can be used to distinguish systemic lupus erythematosus (SLE) patients from healthy controls, but further refinement is needed to differentiate between lupus patients with and without neuropsychiatric manifestations. Elevated levels of specific molecules in the cerebrospinal fluid and/or serum, as well as the presence of certain autoantibodies, have been identified as potential biomarkers in attempts to facilitate a more accurate and objective diagnosis. Among such autoantibodies, anti-NR2 and anti-ribosomal P autoantibodies also have a pathogenic role, although newer studies demonstrate that blood-brain barrier damage may not always be required as previously believed. These and other observations, together with new evidence for disease attenuation after microglial modulation, suggest direct involvement of the central nervous system in NPSLE pathogenesis. Neuropsychiatric involvement of SLE includes a variety of symptoms that impact quality of life and patient prognosis. There have been recent advances in improving the diagnosis of NPSLE as well as in dissecting the underlying pathogenesis. The attenuation of neuropsychiatric disease in mouse models demonstrates the potential for targeted therapies, which are based on a clearer understanding of the pathogenesis of NPSLE. Further assessment of these treatments is required in NPSLE patients, as well as the potential use of neuroimaging to distinguish between SLE patients with or without neuropsychiatric manifestations.
引用
收藏
页码:152 / 158
页数:7
相关论文
共 50 条
  • [1] Advances in Diagnosis and Treatment of Neuropsychiatric Systemic Lupus Erythematosus
    Shufei Zeng
    Yangyang Zang
    Dezhen Chen
    Baozhang Guan
    Fanna Liu
    Mingming Ma
    Yu Mong
    Huiyuan Zheng
    Aiyun Cha
    Xiangnan Dong
    Huanhuan Liu
    Taksui Wong
    Shuang Cui
    Tong Liu
    Yongpin Lu
    Chen Yun
    Hongwei Hu
    B.Hocher
    W.Pommer
    Zuhui Chen
    Lianghong Yin
    [J]. 临床医学工程, 2017, (S1) : 37 - 39
  • [2] Pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus: A review
    Liu, Yuhong
    Tu, Zhihua
    Zhang, Xi
    Du, Keqian
    Xie, Zhengquan
    Lin, Zhiming
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [3] Progress in the Pathogenesis and Treatment of Neuropsychiatric Systemic Lupus Erythematosus
    Wang, Minhui
    Wang, Ziqian
    Zhang, Shangzhu
    Wu, Yang
    Li, Zhang
    Zhao, Jiuliang
    Wang, Qian
    Tian, Xinping
    Li, Mengtao
    Zeng, Xiaofeng
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (17)
  • [4] Advances in the Pathogenesis and Treatment of Systemic Lupus Erythematosus
    Accapezzato, Daniele
    Caccavale, Rosalba
    Paroli, Maria Pia
    Gioia, Chiara
    Nguyen, Bich Lien
    Spadea, Luca
    Paroli, Marino
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [5] Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers
    Jeltsch-David, Helene
    Muller, Sylviane
    [J]. NATURE REVIEWS NEUROLOGY, 2014, 10 (10) : 579 - 596
  • [6] Lupus and the Brain: Advances in Neuropsychiatric Systemic Lupus Erythematosus
    Fanouriakis, Antonis
    Bertsias, George
    Govoni, Marcello
    [J]. FRONTIERS IN MEDICINE, 2019, 6
  • [7] Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers
    Hélène Jeltsch-David
    Sylviane Muller
    [J]. Nature Reviews Neurology, 2014, 10 : 579 - 596
  • [8] Pathogenesis of neuropsychiatric systemic lupus erythematosus and potential biomarkers
    Efthimiou, Petros
    Blanco, Michelle
    [J]. MODERN RHEUMATOLOGY, 2009, 19 (05) : 457 - 468
  • [9] Neuropsychiatric systemic lupus erythematosus: Tools for the diagnosis
    Zardi, Enrico Maria
    Taccone, Arianna
    Marigliano, Benedetta
    Margiotta, Domenico P. E.
    Afeltra, Antonella
    [J]. AUTOIMMUNITY REVIEWS, 2014, 13 (08) : 831 - 839
  • [10] Advances in the study of exosome-derived miRNAs in the pathogenesis, diagnosis, and treatment of systemic lupus erythematosus
    Wu, Yu
    Dong, Hai Rong
    Liu, Li Tin
    Peng, Mei Lin
    Su, Xiu Lan
    [J]. LUPUS, 2023, 32 (13) : 1475 - 1485